Loading clinical trials...
Loading clinical trials...
A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of ARCR Augmented With REGENETEN™ Bioinductive Implant System in Full-thickness Tears (Large or Massive) Repair Versus ARCR Alone
Conditions
Interventions
Arthroscopic rotator cuff repair with REGENETEN™ Bioinductive Implant augmentation
Arthroscopic rotator cuff repair
+1 more
Locations
30
United States
Harbin Clinic
Rome, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
Sinai Hospital
Baltimore, Maryland, United States
Syracuse Orthopedic Specialists
DeWitt, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Texas Orthopedic Specialists
Bedford, Texas, United States
Start Date
December 7, 2020
Primary Completion Date
October 31, 2023
Completion Date
October 31, 2023
Last Updated
May 23, 2025
NCT06381791
NCT04923477
NCT05444465
NCT07289893
NCT06505135
NCT06318403
Lead Sponsor
Smith & Nephew, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions